Abortion Pill Maker Eyes Changed Judiciary as It Mulls New Suit

Sept. 14, 2022, 9:30 AM UTC

Generic abortion pill maker GenBioPro is searching for a new court to revive its battle against state restrictions, though the company’s hunt for a favorable judicial forum will prove complicated thanks to appointments from the Trump administration.

Former President Donald Trump’s shakeup of the judiciary has created unpredictable arenas as GenBioPro plans out its next legal challenge to ensure access to the pill mifepristone. The drugmaker voluntarily dropped its lawsuit in Mississippi challenging statewide abortion restrictions but has since signaled its intent to bring suit elsewhere.

“We’re not done with the battle by any means,” said Kenneth Parsigian, a Latham ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.